vydura
pfizer europe ma eeig - rimegepant - migrene lidelser - antimigraine preparations, calcitonin gene-related peptide (cgrp) antagonists - vydura is indicated for theacute treatment of migraine with or without aura in adults;preventative treatment of episodic migraine in adults who have at least 4 migraine attacks per month.
wakix 4.5 mg
paranova as - pitolisanthydroklorid - tablett, filmdrasjert - 4.5 mg
wakix 18 mg
paranova as - pitolisanthydroklorid - tablett, filmdrasjert - 18 mg
lorviqua
pfizer europe ma eeig - lorlatinib - karsinom, ikke-småcellet lunge - antineoplastic agents, protein kinase inhibitors - lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. lorviqua as monotherapy is indicated for the treatment of adult patients with alk‑positive advanced nsclc whose disease has progressed after:alectinib or ceritinib as the first alk tyrosine kinase inhibitor (tki) therapy; orcrizotinib and at least one other alk tki.
xyrem
ucb pharma ltd - natriumoksybat - cataplexy; narcolepsy - andre nervesystemet narkotika - behandling av narkolepsi med katapleksi hos voksne pasienter.
bosulif 400 mg
abacus medicine a/s - bosutinibmonohydrat - tablett, filmdrasjert - 400 mg
ozawade
bioprojet pharma - pitolisant - sleep apnea, obstructive - andre nervesystemet narkotika - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).
bosulif 100 mg
2care4 aps - bosutinibmonohydrat - tablett, filmdrasjert - 100 mg
bosulif 400 mg
2care4 aps - bosutinibmonohydrat - tablett, filmdrasjert - 400 mg
venclyxto 10 mg
abacus medicine a/s - venetoklaks - tablett, filmdrasjert - 10 mg